CoChat

The Platelet Response to Tissue Injury

Open access
Eisinger, Felix, Patzelt, Johannes, Langer, Harald F. · 2018 · Frontiers in Medicine
Cited by 154

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

In recent years, various studies have increasingly explained platelet functions not only in their central role as a regulator in cellular hemostasis and coagulation. In fact, there is growing evidence that under specific conditions, platelets act as a mediator between the vascular system, hemostasis, and the immune system. Therefore, they are essential in many processes involved in tissue remodeling and tissue reorganization after injury or inflammatory responses. These processes include the promotion of inflammatory processes, the contribution to innate and adaptive immune responses during bacterial and viral infections, the modulation of angiogenesis, and the regulation of cell apoptosis in steady-state tissue homeostasis or after tissue breakdown. All in all platelets may contribute to the control of tissue homeostasis much more than generally assumed. This review summarizes the current knowledge of platelets as part of the tissue remodeling network and seeks to provide possible translational implications for clinical therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmed.2018.00317

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 189

  1. Nieswandt, 2011, Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke, J Thromb Haemost, 9, 92, 10.1111/j.1538-7836.2011.04361.x · DOI · Paper page
  2. Gawaz, 2005, Platelets in inflammation and atherogenesis, J Clin Invest., 115, 3378, 10.1172/JCI27196 · DOI · Paper page
  3. Franco, 2015, Platelets at the interface of thrombosis, inflammation, and cancer, Blood, 126, 582, 10.1182/blood-2014-08-531582 · DOI · Paper page
  4. Langer, 2013, Platelets and neurovascular inflammation, Thromb Haemost., 110, 888, 10.1160/TH13-02-0096 · DOI
  5. Semple, 2011, Platelets and the immune continuum, Nat Rev Immunol, 11, 264, 10.1038/nri2956 · DOI · Paper page
  6. Koupenova, 2018, Circulating platelets as mediators of immunity, inflammation, and thrombosis, Circ Res, 122, 337, 10.1161/CIRCRESAHA.117.310795 · DOI · Paper page
  7. Weyrich, 2003, The evolving role of platelets in inflammation, J Thromb Haemost, 1, 1897, 10.1046/j.1538-7836.2003.00304.x · DOI · Paper page
  8. Giles, 1981, The platelet count and mean platelet volume, Br J Haematol, 48, 31, 10.1111/j.1365-2141.1981.00031.x · DOI · Paper page
  9. Savage, 1996, Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von willebrand factor, Cell, 84, 289, 10.1016/S0092-8674(00)80983-6 · DOI · Paper page
  10. Konstantinides, 2006, Distinct antithrombotic consequences of platelet glycoprotein Ib?? and VI deficiency in a mouse model of arterial thrombosis, J Thromb Haemost, 4, 2014, 10.1111/j.1538-7836.2006.02086.x · doi:10.1111/j.1538-7836.2006.02086.x
  11. Lecut, 2004, Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation, Arter Thromb Vasc Biol, 24, 1727, 10.1161/01.ATV.0000137974.85068.93 · DOI
  12. Nieswandt, 2001, Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen, EMBO J, 20, 2120, 10.1093/emboj/20.9.2120 · DOI · Paper page
  13. Flaumenhaft, 2013, Platelet secretion, Platelets, 343, 10.1016/B978-0-12-387837-3.00018-3 · DOI
  14. Holmsen, 1979, Secretable storage pools in platelets, Annu Rev Med, 30, 119, 10.1146/annurev.me.30.020179.001003 · DOI
  15. Maynard, 2007, Proteomic analysis of platelet α-granules using mass spectrometry, J Thromb Haemost, 5, 1945, 10.1111/j.1538-7836.2007.02690.x · DOI · Paper page
  16. Cramer, 1990, Alpha-granule pool of glycoprotein IIb-IIIa in normal and pathologic platelets and megakaryocytes, Blood, 75, 1220, 10.1182/blood.V75.6.1220.1220 · doi:10.1182/blood.v75.6.1220.1220
  17. Paul, 1999, Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change, J Biol Chem, 274, 28293, 10.1074/jbc.274.40.28293 · DOI · Paper page
  18. Gawaz, 1997, Vitronectin receptor (αvβ3) mediates platelet adhesion to the luminal aspect of endothelial cells, Circulation, 96, 1809, 10.1161/01.CIR.96.6.1809 · DOI · Paper page
  19. Phillips, 1988, The platelet membrane glycoprotein IIb-IIIa complex, Blood, 71, 831, 10.1182/blood.V71.4.831.831 · DOI · Paper page
  20. Xu, 2013, Integrity of kindlin-2 FERM subdomains is required for supporting integrin activation, Biochem Biophys Res Commun, 434, 382, 10.1016/J.BBRC.2013.03.086 · DOI
  21. Haling, 2011, Talin-dependent integrin activation is required for fibrin clot retraction by platelets, Blood, 117, 1719, 10.1182/blood-2010-09-305433 · DOI
  22. Durrant, 2017, Integrin αIIbβ3 outside-in signaling, Blood, 130, 1607, 10.1182/blood-2017-03-773614 · DOI · Paper page
  23. Coller, 2008, The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend, Blood, 112, 3011, 10.1182/blood-2008-06-077891 · DOI · Paper page
  24. Needleman, 1976, Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides, Nature, 261, 558, 10.1038/261558a0 · DOI · Paper page
  25. Kahn, 1999, Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin, J Clin Invest, 103, 879, 10.1172/JCI6042 · DOI · Paper page
  26. Dorsam, 2004, Central role of the P2Y12 receptor in platelet activation, J Clin Invest., 113, 340, 10.1172/JCI20986 · doi:10.1172/jci20986 · Paper page
  27. Sabatine, 2005, Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation, N Engl J Med, 352, 1179, 10.1056/NEJMoa050522 · DOI · Paper page
  28. Hollopeter, 2001, Identification of the platelet ADP receptor targeted by antithromboticdrugs, Nature, 409, 202, 10.1038/35051599 · DOI · Paper page
  29. McEver, 1984, A monoclonal antibody to a membrane glycoprotein binds only to activated platelets, J Biol Chem, 259, 9799, 10.1016/S0021-9258(17)42770-0 · DOI · Paper page
  30. Verschoor, 2011, A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3, Nat Immunol, 12, 1194, 10.1038/ni.2140 · DOI · Paper page
  31. Furie, 2004, Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation, Trends Mol Med, 10, 171, 10.1016/J.MOLMED.2004.02.008 · DOI · Paper page
  32. Wang, 2017, Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα, Nat Commun, 8, 15559, 10.1038/ncomms15559 · DOI · Paper page
  33. Larsen, 1989, PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes, Cell, 59, 305, 10.1016/0092-8674(89)90292-4 · DOI · Paper page
  34. De Luca, 1995, A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding, J Biol Chem, 270, 26734, 10.1074/JBC.270.45.26734 · DOI
  35. de Bruijne-Admiraal, 1992, P-selectin mediates Ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry, Blood, 80, 134, 10.1182/blood.V80.1.134.134 · DOI · Paper page
  36. Palabrica, 1992, Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets, Nature, 359, 848, 10.1038/359848a0 · DOI · Paper page
  37. da Costa Martins, 2004, Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation, Arterioscler Thromb Vasc Biol, 24, 193, 10.1161/01.ATV.0000106320.40933.E5 · DOI
  38. Wang, 2005, Leukocyte engagement of platelet glycoprotein Ibα via the integrin Mac-1 is critical for the biological response to vascular injury, Circulation, 112, 2993, 10.1161/CIRCULATIONAHA.105.571315 · DOI · Paper page
  39. Diacovo, 1996, Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18, Blood, 88, 146, 10.1182/blood.V88.1.146.146 · DOI · Paper page
  40. Kuijper, 1998, Platelet associated fibrinogen and ICAM-2 induce firm adhesion of neutrophils under flow conditions, Thromb Haemost., 80, 443, 10.1055/s-0037-1615227 · doi:10.1055/s-0037-1615227
  41. Théorêt, 2011, P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation, Thromb Res, 128, 243, 10.1016/J.THROMRES.2011.04.018 · DOI
  42. Collins, 2000, P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice, J Exp Med, 191, 189, 10.1084/JEM.191.1.189 · DOI · Paper page
  43. Burger, 2003, Platelet P-selectin facilitates atherosclerotic lesion development, Blood, 101, 2661, 10.1182/blood-2002-07-2209 · DOI · Paper page
  44. Stähli, 2016, Effects of P-selectin antagonist inclacumab in patients undergoing coronary artery bypass graft surgery: SELECT-CABG trial, J Am Coll Cardiol, 67, 344, 10.1016/J.JACC.2015.10.071 · DOI
  45. Shah, 2017, Platelet–eosinophil interactions as a potential therapeutic target in allergic inflammation and asthma, Front Med, 4, 129, 10.3389/fmed.2017.00129 · doi:10.3389/fmed.2017.00129
  46. Kroczek, 1998, CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells, Nature, 391, 591, 10.1038/35393 · DOI · Paper page
  47. Jin, 2001, Characterization of soluble CD40 ligand released from human activated platelets, J Med Dent Sci, 48, 23, 10.11480/jmds.480104 · doi:10.11480/jmds.480104
  48. Hollenbaugh, 1995, Expression of functional CD40 by vascular endothelial cells, J Exp Med, 182, 33, 10.1084/jem.182.1.33 · DOI · Paper page
  49. Lindmark, 2000, Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression, Arterioscler Thromb Vasc Biol, 20, 2322, 10.1161/01.ATV.20.10.2322 · DOI · Paper page
  50. Sanguigni, 2005, CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia, J Am Coll Cardiol, 45, 35, 10.1016/j.jacc.2004.09.047 · DOI
  51. Déchanet, 1997, CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells, J Immunol, 159, 5640, 10.4049/jimmunol.159.11.5640 · DOI · Paper page
  52. André, 2002, CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism, Nat Med, 8, 247, 10.1038/nm0302-247 · DOI · Paper page
  53. Lievens, 2010, Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis, Blood, 116, 4317, 10.1182/blood-2010-01-261206 · DOI · Paper page
  54. Lindemann, 2001, Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis, J Cell Biol, 154, 485, 10.1083/jcb.200105058 · DOI · Paper page
  55. Brown, 2011, Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles, J Immunol, 186, 5489, 10.4049/jimmunol.1001623 · DOI · Paper page
  56. Puhlmann, 2005, Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity, J Transl Med, 3, 37, 10.1186/1479-5876-3-37 · DOI · Paper page
  57. Kaplanski, 1994, Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism, Blood, 84, 4242, 10.1182/blood.V84.12.4242.bloodjournal84124242 · DOI · Paper page
  58. Hawrylowicz, 1991, Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production, J Exp Med, 174, 785, 10.1084/jem.174.4.785 · DOI · Paper page
  59. Pillitteri, 2007, Thrombin-induced interleukin 1 beta synthesis in platelet suspensions: Impact of contaminating leukocytes, Platelets, 18, 119, 10.1080/09537100600800792 · DOI
  60. Kameyoshi, 1992, Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils, J Exp Med, 176, 587, 10.1084/jem.176.2.587 · DOI · Paper page
  61. von Hundelshausen, 2001, RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium, Circulation, 103, 1772, 10.1161/01.CIR.103.13.1772 · DOI · Paper page
  62. Mause, 2005, Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium, Arterioscler Thromb Vasc Biol, 25, 1512, 10.1161/01.ATV.0000170133.43608.37 · DOI · Paper page
  63. Schober, 2002, Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury, Circulation, 106, 1523, 10.1161/01.CIR.0000028590.02477.6F · DOI · Paper page
  64. von Hundelshausen, 2005, Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium, Blood, 105, 924, 10.1182/blood-2004-06-2475 · DOI · Paper page
  65. Alard, 2015, Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5, Sci Transl Med, 7, 317, 10.1126/scitranslmed.aad5330 · DOI
  66. Machlus, 2016, CCL5 derived from platelets increases megakaryocyte proplatelet formation, Blood, 127, 921, 10.1182/blood-2015-05-644583 · DOI
  67. Deuel, 1981, Platelet factor 4 is chemotactic for neutrophils and monocytes, Proc Natl Acad Sci USA., 78, 4584, 10.1073/pnas.78.7.4584 · DOI · Paper page
  68. Petersen, 1996, TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines, J Immunol J Immunol by guest Febr J Fmmunofogy, 156, 1954
  69. Kasper, 2007, Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways, J Immunol, 179, 2584, 10.4049/jimmunol.179.4.2584 · DOI
  70. Scheuerer, 2000, The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages, Blood, 95, 1158, 10.1055/s-2008-1056828 · doi:10.1055/s-2008-1056828
  71. Pervushina, 2004, Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients, J Immunol, 173, 2060, 10.4049/JIMMUNOL.173.3.2060 · DOI
  72. Koenen, 2009, Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice, Nat Med, 15, 97, 10.1038/nm.1898 · DOI · Paper page
  73. Fan, 2016, MKEY, a Peptide Inhibitor of CXCL4-CCL5 heterodimer formation, protects against stroke in mice, J Am Heart Assoc, 5, e003615, 10.1161/JAHA.116.003615 · DOI
  74. Kapur, 2015, Nouvelle cuisine: platelets served with inflammation, J Immunol, 194, 5579, 10.4049/jimmunol.1500259 · DOI · Paper page
  75. Martinod, 2014, Thrombosis: tangled up in NETs, Blood, 123, 2768, 10.1182/blood-2013-10-463646 · DOI · Paper page
  76. Kraemer, 2011, Novel anti-bacterial activities of β-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation, PLoS Pathog., 7, e1002355, 10.1371/journal.ppat.1002355 · DOI · Paper page
  77. Etulain, 2015, P-selectin promotes neutrophil extracellular trap formation in mice, Blood, 126, 242, 10.1182/blood-2015-01-624023 · DOI · Paper page
  78. Haselmayer, 2007, TREM-1 ligand expression on platelets enhances neutrophil activation, Blood, 110, 1029, 10.1182/blood-2007-01-069195 · DOI · Paper page
  79. Iannacone, 2005, Platelets mediate cytotoxic T lymphocyte–induced liver damage, Nat Med, 11, 1167, 10.1038/nm1317 · DOI · Paper page
  80. Elzey, 2003, Platelet-mediated modulation of adaptive immunity: a communication link between innate and adaptive immune compartments, Immunity, 19, 9, 10.1016/S1074-7613(03)00177-8 · DOI · Paper page
  81. Elzey, 2008, Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge, Blood, 111, 3684, 10.1182/blood-2007-05-091728 · DOI
  82. Lang, 2008, Aggravation of viral hepatitis by platelet-derived serotonin, Nat Med., 14, 756, 10.1038/nm1780 · DOI · Paper page
  83. Leon-Ponte, 2007, Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor, Blood, 109, 3139, 10.1182/blood-2006-10-052787 · DOI · Paper page
  84. Crawford, 2011, A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection, PLoS Pathog, 7, e1002098, 10.1371/journal.ppat.1002098 · DOI · Paper page
  85. Yeaman, 2014, Platelets: at the nexus of antimicrobial defence, Nat Rev Microbiol, 12, 426, 10.1038/nrmicro3269 · DOI · Paper page
  86. McMorran, 2009, Platelets kill intraerythrocytic malarial parasites and mediate survival to infection, Science, 323, 797, 10.1126/science.1166296 · DOI · Paper page
  87. McMorran, 2012, Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum, Science, 338, 1348, 10.1126/science.1228892 · DOI
  88. Love, 2012, Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials, Cell Host Microbe, 12, 815, 10.1016/j.chom.2012.10.017 · DOI
  89. Gramaglia, 2017, Platelets activate a pathogenic response to blood-stage Plasmodium infection but not a protective immune response, Blood, 129, 1669, 10.1182/blood-2016-08-733519 · DOI
  90. Kho, 2018, Platelets kill circulating parasites of all major Plasmodium species in human malaria, Blood, 132, 1332, 10.1182/blood-2018-05-849307 · DOI
  91. Krauel, 2011, Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia, Blood, 117, 1370, 10.1182/blood-2010-08-301424 · doi:10.1182/blood-2010-08-301424
  92. Palankar, 2018, Platelets kill bacteria by bridging innate and adaptive immunity via PF4 and FcγRIIA, J Thromb Haemost, 16, 1187, 10.1111/jth.13955 · DOI
  93. Shi, 2014, Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection, J Clin Invest, 124, 543, 10.1172/JCI71858 · DOI · Paper page
  94. Krijgsveld, 2000, Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines, J Biol Chem, 275, 20374, 10.1074/JBC.275.27.20374 · DOI · Paper page
  95. Kwakman, 2011, Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements, J Biol Chem., 286, 43506, 10.1074/jbc.M111.248641 · DOI
  96. Patzelt, 2015, Platelets and the complement cascade in atherosclerosis, Front Physiol, 6, 49, 10.3389/fphys.2015.00049 · DOI
  97. Nording, 2018, Complement links platelets to innate immunity, Semin Immunol, 10.1016/j.smim.2018.01.003 · DOI
  98. Verschoor, 2013, Crosstalk between platelets and the complement system in immune protection and disease, Thromb Haemost, 110, 910, 10.1160/TH13-02-0102 · DOI
  99. del Conde, 2005, Platelet activation leads to activation and propagation of the complement system, J Exp Med, 201, 871, 10.1084/jem.20041497 · DOI · Paper page
  100. Wuescher, 2015, A novel conditional platelet depletion mouse model reveals the importance of platelets in protection against Staphylococcus aureus bacteremia, J Thromb Haemost, 13, 303, 10.1111/jth.12795 · DOI
  101. Boilard, 2014, Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation, Blood, 123, 2854, 10.1182/blood-2013-07-515536 · DOI · Paper page
  102. Arman, 2014, Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4, Blood, 123, 3166, 10.1182/blood-2013-11-540526 · DOI · Paper page
  103. Patzelt, 2012, Langer H. Platelets in angiogenesis, Curr Vasc Pharmacol, 10, 570, 10.2174/157016112801784648 · DOI
  104. Stellos, 2008, Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells, Circulation, 117, 206, 10.1161/CIRCULATIONAHA.107.714691 · DOI · Paper page
  105. Italiano, 2008, Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released, Blood, 111, 1227, 10.1182/blood-2007-09-113837 · DOI · Paper page
  106. Chatterjee, 2011, Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli, Blood, 117, 3907, 10.1182/blood-2010-12-327007 · DOI · Paper page
  107. Battinelli, 2011, Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis, Blood, 118, 1359, 10.1182/blood-2011-02-334524 · DOI · Paper page
  108. Kamykowski, 2011, Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet α-granules, Blood, 118, 1370, 10.1182/blood-2011-01-330910 · DOI
  109. Jonnalagadda, 2012, Platelet secretion is kinetically heterogeneous in an agonist-responsive manner, Blood, 120, 5209, 10.1182/blood-2012-07-445080 · DOI · Paper page
  110. Arisato, 2003, Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region, J Thromb Haemost, 1, 2589, 10.1046/j.1538-7836.2003.00475.x · DOI
  111. Pintucci, 2002, Trophic effects of platelets on cultured endothelial cells are mediated by platelet - associated fibroblast growth factor - 2 ( FGF - 2 ) and vascular endothelial growth factor ( VEGF ), Thromb Haemost, 88, 834, 10.1267/th02110834 · doi:10.1267/th02110834
  112. Oka, 1983, Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets, J Clin Invest, 72, 249, 10.1172/JCI110964 · doi:10.1172/jci110964
  113. English, 2000, Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis, FASEB J, 14, 2255, 10.1096/fj.00-0134com · DOI · Paper page
  114. Li, 2001, Thrombin induces the release of angiopoietin-1 from platelets, Thromb Haemost, 85, 204, 10.1055/s-0037-1615677 · DOI
  115. Miyazono, 1987, Purification and properties of an endothelial cell growth factor from human platelets, J Biol Chem, 262, 4098, 10.1016/S0021-9258(18)61316-X · doi:10.1016/s0021-9258(18)61316-x
  116. De Smet, 2009, Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way, Arterioscler Thromb Vasc Biol, 29, 639, 10.1161/ATVBAHA.109.185165 · DOI · Paper page
  117. Johnson, 2017, Tamoxifen directly inhibits platelet angiogenic potential and platelet-mediated metastasis, Arterioscler Thromb Vasc Biol, 37, 664, 10.1161/ATVBAHA.116.308791 · DOI
  118. Seghezzi, 1998, Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis, J Cell Biol, 141, 1659, 10.1083/JCB.141.7.1659 · DOI · Paper page
  119. Li, 2016, Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects, Cancer Lett, 377, 164, 10.1016/J.CANLET.2016.04.036 · DOI
  120. Jonnalagadda, 2014, Granule-mediated release of sphingosine-1-phosphate by activated platelets, Biochim Biophys Acta, 1841, 1581, 10.1016/j.bbalip.2014.08.013 · DOI
  121. Kubilus, 1978, Purification of thymidine phosphorylase from human amniochorion, Biochim Biophys Acta Enzymol, 527, 221, 10.1016/0005-2744(78)90271-1 · doi:10.1016/0005-2744(78)90271-1
  122. Furukawa, 1992, Angiogenic factor, Nature, 356, 668, 10.1038/356668a0 · DOI · Paper page
  123. Ishikawa, 1989, Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor, Nature, 338, 557, 10.1038/338557a0 · DOI · Paper page
  124. Miyadera, 1995, Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase, Cancer Res, 55, 1687
  125. Brown, 1998, Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis, Biochem J, 334, 1, 10.1042/bj3340001 · DOI · Paper page
  126. Bijnsdorp, 2011, Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors, Br J Cancer, 104, 1185, 10.1038/bjc.2011.74 · DOI
  127. Pula, 2010, Paracrine stimulation of endothelial cell motility and angiogenesis by platelet-derived deoxyribose-1-phosphate, Arterioscler Thromb Vasc Biol, 30, 2631, 10.1161/ATVBAHA.110.215855 · doi:10.1161/atvbaha.110.215855
  128. Moghaddam, 1995, Thymidine phosphorylase is angiogenic and promotes tumor growth, Proc Natl Acad Sci USA, 92, 998, 10.1073/PNAS.92.4.998 · DOI · Paper page
  129. O'Byrne, 2000, Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer, Br J Cancer, 82, 1427, 10.1054/bjoc.1999.1129 · DOI · Paper page
  130. Fujimoto, 1999, Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers, Br J Cancer, 79, 1249, 10.1038/sj.bjc.6690200 · DOI
  131. Mizutani, 2003, The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma, Cancer, 98, 730, 10.1002/cncr.11570 · doi:10.1002/cncr.11570
  132. Li, 2014, Thymidine phosphorylase participates in platelet signaling and promotes thrombosis, Circ Res, 115, 997, 10.1161/CIRCRESAHA.115.304591 · DOI
  133. van Hinsbergh, 2008, Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead, Cardiovasc Res, 78, 203, 10.1093/cvr/cvm102 · DOI · Paper page
  134. Seizer, 2013, Platelets and matrix metalloproteinases, Thromb Haemost, 110, 903, 10.1160/TH13-02-0113 · DOI
  135. Thurston, 2000, Angiopoietin-1 protects the adult vasculature against plasma leakage, Nat Med, 6, 460, 10.1038/74725 · DOI · Paper page
  136. Daly, 2018, Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor, Sci Rep, 8, 505, 10.1038/s41598-017-18912-8 · DOI
  137. Bowen-Pope, 2011, History of discovery: platelet-derived growth factor, Arterioscler Thromb Vasc Biol, 31, 2397, 10.1161/ATVBAHA.108.179556 · DOI
  138. De Marchis, 2002, Platelet-derived growth factor inhibits basic fibroblast growth factor angiogenic properties in vitro and in vivo through its alpha receptor, Blood, 99, 2045, 10.1182/blood.V99.6.2045 · DOI
  139. Eberhard, 2000, Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies, Cancer Res, 60, 1388
  140. Zaslavsky, 2010, Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis, Blood, 115, 4605, 10.1182/blood-2009-09-242065 · DOI · Paper page
  141. Maione, 1990, Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides, Science, 247, 77, 10.1126/SCIENCE.1688470 · DOI · Paper page
  142. Klement, 2009, Platelets actively sequester angiogenesis regulators, Blood, 113, 2835, 10.1182/blood-2008-06-159541 · DOI · Paper page
  143. Kasthuri, 2009, Role of tissue factor in cancer, J Clin Oncol, 27, 4834, 10.1200/JCO.2009.22.6324 · DOI · Paper page
  144. Jain, 2010, Platelets: linking hemostasis and cancer, Arterioscler Thromb Vasc Biol, 30, 2362, 10.1161/ATVBAHA.110.207514 · DOI · Paper page
  145. Varki, 2007, Trousseau's syndrome: multiple definitions and multiple mechanisms, Blood, 110, 1723, 10.1182/blood-2006-10-053736 · DOI · Paper page
  146. Battinelli, 2014, Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response, Blood, 123, 101, 10.1182/blood-2013-02-485011 · doi:10.1182/blood-2013-02-485011
  147. Etulain, 2013, Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin, Br J Pharmacol., 170, 255, 10.1111/bph.12250 · DOI
  148. Kisucka, 2006, Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage, Proc Natl Acad Sci USA., 103, 855, 10.1073/pnas.0510412103 · DOI · Paper page
  149. Brill, 2005, Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization, Cardiovasc Res, 67, 30, 10.1016/j.cardiores.2005.04.007 · DOI · Paper page
  150. Vu, 2015, An autologous platelet-rich plasma hydrogel compound restores left ventricular structure, function and ameliorates adverse remodeling in a minimally invasive large animal myocardial restoration model: a translational approach, Biomaterials, 45, 27, 10.1016/j.biomaterials.2014.12.013 · DOI
  151. Zhou, 2013, Rapidly in situ forming platelet-rich plasma gel enhances angiogenic responses and augments early wound healing after open abdomen, Gastroenterol Res Pract, 2013, 926764, 10.1155/2013/926764 · DOI
  152. Mao, 2018, VEGF-A/VEGFR-2 and FGF-2/FGFR-1 but not PDGF-BB/PDGFR-β play important roles in promoting immature and inflammatory intraplaque angiogenesis, PLoS ONE, 13, e0201395, 10.1371/journal.pone.0201395 · DOI
  153. Hussain, 2017, An evidence-based evaluation on the use of platelet rich plasma in orthopedics - a review of the literature, SICOT-J, 3, 57, 10.1051/sicotj/2017036 · DOI
  154. Picard, 2015, Should we use platelet-rich plasma as an adjunct therapy to treat “acute wounds,” “burns,” and “laser therapies”: A review and a proposal of a quality criteria checklist for further studies, Wound Repair Regen, 23, 163, 10.1111/wrr.12266 · doi:10.1111/wrr.12266
  155. Suthar, 2017, Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series, J Biomed Sci, 24, 16, 10.1186/s12929-017-0324-1 · doi:10.1186/s12929-017-0324-1
  156. Schleicher, 2015, Platelets induce apoptosis via membrane-bound FasL, Blood, 126, 1483, 10.1182/blood-2013-12-544445 · DOI
  157. Langer, 2007, Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro, Arterioscler Thromb Vasc Biol, 27, 1463, 10.1161/ATVBAHA.107.141515 · DOI
  158. Wassmer, 2006, TGF-beta1 released from activated platelets can induce TNF-stimulated human brain endothelium apoptosis: a new mechanism for microvascular lesion during cerebral malaria, J Immunol, 176, 1180, 10.4049/JIMMUNOL.176.2.1180 · doi:10.4049/jimmunol.176.2.1180
  159. Sharron, 2012, Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade, PLoS ONE, 7, e41549, 10.1371/journal.pone.0041549 · DOI
  160. Wong, 2007, Anti-apoptotic effect of sphingosine-1-phosphate and platelet-derived growth factor in human embryonic stem cells, Stem Cells Dev, 16, 989, 10.1089/scd.2007.0057 · DOI
  161. Harrington, 1994, c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines, EMBO J, 13, 3286, 10.1002/j.1460-2075.1994.tb06630.x · DOI · Paper page
  162. Massberg, 2006, Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo, J Exp Med, 203, 1221, 10.1084/jem.20051772 · DOI · Paper page
  163. Zernecke, 2005, SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells, Circ Res, 96, 784, 10.1161/01.RES.0000162100.52009.38 · DOI · Paper page
  164. Chen, 2015, Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration, Sci Rep, 5, 16813, 10.1038/srep16813 · DOI
  165. Abbott, 2004, Stromal cell-derived factor-1 plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury, Circulation, 110, 3300, 10.1161/01.CIR.0000147780.30124.CF · DOI · Paper page
  166. Rafii, 2015, Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration, Nat Cell Biol, 17, 123, 10.1038/ncb3096 · DOI · Paper page
  167. Langer, 2009, Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro, J Mol Cell Cardiol, 47, 315, 10.1016/j.yjmcc.2009.03.011 · DOI
  168. Vogel, 2010, Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells, Cell Mol Life Sci, 67, 295, 10.1007/s00018-009-0183-3 · DOI
  169. Vogel, 2014, Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET, J Biol Chem, 289, 11068, 10.1074/jbc.M113.530287 · DOI
  170. Ho-Tin-Noé, 2018, Platelets and vascular integrity: how platelets prevent bleeding in inflammation, Blood, 131, 277, 10.1182/blood-2017-06-742676 · DOI · Paper page
  171. Pollitt, 2013, GPVI and CLEC-2, Platelets, 215, 10.1016/B978-0-12-387837-3.00011-0 · DOI
  172. Boulaftali, 2013, Platelet ITAM signaling is critical for vascular integrity in inflammation, J Clin Invest, 123, 908, 10.1172/JCI65154 · DOI · Paper page
  173. Goerge, 2008, Inflammation induces hemorrhage in thrombocytopenia, Blood, 111, 4958, 10.1182/blood-2007-11-123620 · DOI · Paper page
  174. Gros, 2015, Single platelets seal neutrophil-induced vascular breaches via GPVI during immune-complex-mediated inflammation in mice, Blood, 126, 1017, 10.1182/blood-2014-12-617159 · DOI · Paper page
  175. Rayes, 2017, The podoplanin-CLEC-2 axis inhibits inflammation in sepsis, Nat Commun, 8, 2239, 10.1038/s41467-017-02402-6 · DOI
  176. Haining, 2017, CLEC-2 contributes to hemostasis independently of classical hemITAM signaling in mice, Blood, 130, 2224, 10.1182/blood-2017-03-771907 · DOI
  177. Lesurtel, 2006, Platelet-derived serotonin mediates liver regeneration, Science, 312, 104, 10.1126/science.1123842 · DOI · Paper page
  178. Nocito, 2007, Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice, Hepatology, 45, 369, 10.1002/hep.21516 · DOI · Paper page
  179. Furrer, 2011, Serotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway, Proc Natl Acad Sci USA., 108, 2945, 10.1073/pnas.1012531108 · DOI · Paper page
  180. Nowatari, 2015, Sphingosine 1-phosphate has anti-apoptotic effect on liver sinusoidal endothelial cells and proliferative effect on hepatocytes in a paracrine manner in human, Hepatol Res, 45, 1136, 10.1111/hepr.12446 · DOI
  181. Shido, 2017, Platelets prime hematopoietic–vascular niche to drive angiocrine-mediated liver regeneration, Signal Transduct Target Ther, 2, 16044, 10.1038/sigtrans.2016.44 · DOI
  182. Xu, 2007, Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis, Am J Respir Cell Mol Biol, 37, 291, 10.1165/rcmb.2006-0187OC · DOI · Paper page
  183. Pitchford, 2004, Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation, Blood, 103, 639, 10.1182/blood-2003-05-1707 · DOI
  184. Park, 2017, Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: the remodeling trial, Thromb Haemost, 117, 911, 10.1160/TH16-10-0744 · doi:10.1160/th16-10-0744
  185. Meyer, 2012, Platelet TGF-β1 contributions to plasma TGF-β1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload, Blood, 119, 1064, 10.1182/blood-2011-09-377648 · DOI · Paper page
  186. Wu, 2017, P2y12 receptor promotes pressure overload–induced cardiac remodeling via platelet-driven inflammation in micenovelty and significance, Hypertension, 70, 759, 10.1161/HYPERTENSIONAHA.117.09262 · DOI
  187. Yang, 2012, Coronary artery remodeling in a model of left ventricular pressure overload is influenced by platelets and inflammatory cells, PLoS ONE, 7, e40196, 10.1371/journal.pone.0040196 · DOI
  188. Walsh, 2017, Platelets protect cardiomyocytes from ischemic damage, TH Open, 1, e24, 10.1055/s-0037-1603928 · DOI
  189. Xu, 2013, Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization, Cells Tissues Organs., 197, 103, 10.1159/000342921 · DOI

Cited by

See all 154

Metadata

Authors
Eisinger, F., Patzelt, J., & Langer, H. F.
Venue
Frontiers in Medicine
Published
2018-11-13
Volume
5
Pages
317-317
ISSN
2296-858X (ISSN-L)
OpenAlex
W2901041585
Cited by
154
References
13
FWCI
7.45
Type
journal article
Language
en
Open access
gold
Funders
  • Deutsche Forschungsgemeinschaft (KFO 274)
  • Volkswagen Foundation (Lichtenberg program)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.